Webinars

Advances in artificial intelligence enable high throughput compound profiling and cell viability analysis. 

Scientists discover an ultra-rare monoclonal antibody directly from patients with autoimmune diseases.

New chemical synthesis technologies speed up the identification and optimization of promising drug candidates.

Automating liver cell counting adds a new layer of support for drug metabolism studies. 

Evaluating drug toxicity to development and reproduction is a critical component of drug safety assessment. 

Researchers develop sensitive blood-based diagnostics to detect tiny traces of cancer. 

Organic molecules with novel biological properties offer new ways to eliminate multidrug-resistant bacteria. 

Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief. 

Diverse genetic and environmental factors such as stress or UV exposure can spark autoimmune diseases. 

Brain organoids serve as avatars for studying human neurobiology and advancing drug discovery for neurological disorders.